Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(2.01) per share which missed the analyst consensus estimate of $(1.75) by 14.86 percent. This is a 28.21 percent increase over losses of $(2.80) per share
Gainers
RenovoRx, Inc. (NASDAQ: RNXT) shares jumped 128% to $12.41. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a potential innovative treatment for pancreatic cancer.
Helius Medical Technologies, Inc. (NASDAQ:HSDT) (Helius or the Company), a neurotech company focused on neurological wellness, today announced it received market authorization from the Australian Therapeutic Goods